Liu Hongliang, Jin Guangfu, Wang Haifeng, Wu Wenting, Liu Yanhong, Qian Ji, Fan Weiwei, Ma Hongxia, Miao Ruifen, Hu Zhibin, Sun Weiwei, Wang Yi, Jin Li, Wei Qingyi, Shen Hongbing, Huang Wei, Lu Daru
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China.
Biomarkers. 2008 Sep;13(6):607-17. doi: 10.1080/13547500802168031.
Polymorphisms of the methyl-CpG binding domain 1 (MBD1) gene may influence MBD1 activity on gene expression profiles, thereby modulating individual susceptibility to lung cancer. To test this hypothesis, we investigated the associations of four MBD1 polymorphisms and lung cancer risk in a Chinese population. Single locus analysis revealed significant associations between two polymorphisms (rs125555 and rs140689) and lung cancer risk (p=0.011 and p=0.005, respectively). Since the two polymorphisms were in linkage disequilibrium, further haplotype analyses were performed and revealed a significant association with lung cancer (global test p-value=0.0041). Our results suggested that MBD1 polymorphisms might be involved in the development of lung cancer. Validation of these findings in larger studies of other populations is needed.
